DEA schedule
Is tobramycin a controlled substance?
Federal schedule for tobramycin from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Tobramycin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tobramycin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted tobramycin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 67 prescription listings from 46 labelers, none with a DEA schedule |
| DEA controlled substances list | tobramycin is not on the list |
Tobramycin NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 10122-820 | BETHKIS | solution | 300 mg/4mL | Chiesi USA, Inc. | None |
| 24492-850 | Kitabis Pak | solution | 300 mg/5mL | Pari Respiratory Equipment, Inc. | None |
| 49502-345 | TOBI | solution | 300 mg/5mL | Viatris Specialty LLC | None |
| 49502-401 | TOBI Podhaler | capsule | 28 mg/1 | Viatris Specialty LLC | None |
| 63323-303 | Tobramycin | injection, powder, for solution | 1200 mg/30mL | Fresenius Kabi USA, LLC | None |
| 63323-303 | Tobramycin | injection, powder, for solution | 1200 mg/30mL | Fresenius Kabi USA, LLC | None |
| 0078-0813 | TOBREX | ointment | 3 mg/g | Novartis Pharmaceuticals Corporation | None |
| 42571-408 | Tobramycin | inhalant | 300 mg/5mL | Micro Labs Limited | None |
| 68083-253 | Tobramycin | injection | 10 mg/mL | Gland Pharma Limited | None |
| 36000-242 | Tobramycin | injection | 40 mg/mL | Baxter Healthcare Corporation | None |
| 36000-244 | Tobramycin | injection | 40 mg/mL | Baxter Healthcare Corporation | None |
| 67457-428 | Tobramycin | injection | 40 mg/mL | Mylan Institutional LLC | None |
| 67457-473 | Tobramycin | injection | 40 mg/mL | Mylan Institutional LLC | None |
| 68083-241 | Tobramycin | injection | 40 mg/mL | Gland Pharma Limited | None |
| 68083-254 | Tobramycin | injection | 40 mg/mL | Gland Pharma Limited | None |
| 70436-110 | tobramycin | injection, powder, for solution | 1200 mg/30mL | Slate Run Pharmaceuticals, LLC | None |
| 39822-0412 | Tobramycin | injection, powder, lyophilized, for solution | 1.2 g/30mL | XGen Pharmaceuticals DJB, Inc. | None |
| 55150-470 | TOBRAMYCIN | injection, powder, lyophilized, for solution | 1.2 g/30mL | Eugia US LLC | None |
| 68083-312 | Tobramycin | injection, powder, lyophilized, for solution | 1.2 g/30mL | Gland Pharma Limited | None |
| 70700-173 | Tobramycin | injection, powder, lyophilized, for solution | 1.2 g/30mL | Xiromed LLC | None |
| 72266-163 | Tobramycin | injection, powder, lyophilized, for solution | 1.2 g/30mL | Fosun Pharma USA Inc | None |
| 72603-160 | Tobramycin | injection, powder, lyophilized, for solution | 1.2 g/30mL | Northstar Rx LLC | None |
| 63323-305 | Tobramycin | injection, solution | 10 mg/mL | Fresenius Kabi USA, LLC | None |
| 0409-3578 | TOBRAMYCIN | injection, solution | 40 mg/mL | Hospira, Inc. | None |
| 63323-306 | Tobramycin | injection, solution | 40 mg/mL | Fresenius Kabi USA, LLC | None |
| 24208-290 | Tobramycin | solution | 3 mg/mL | Bausch & Lomb Incorporated | None |
| 50090-2127 | Tobramycin | solution | 3 mg/mL | A-S Medication Solutions | None |
| 61314-643 | Tobramycin | solution | 3 mg/mL | Sandoz Inc | None |
| 63187-024 | Tobramycin | solution | 3 mg/mL | Proficient Rx LP | None |
| 63187-973 | Tobramycin | solution | 3 mg/mL | Proficient Rx LP | None |
| 66267-936 | Tobramycin | solution | 3 mg/mL | NuCare Pharmaceuticals,Inc. | None |
| 68788-4149 | Tobramycin | solution | 3 mg/mL | Preferred Pharmaceuticals Inc. | None |
| 76420-791 | Tobramycin | solution | 3 mg/mL | Asclemed USA, Inc. | None |
| 80425-0341 | Tobramycin | solution | 3 mg/mL | Advanced Rx Pharmacy of Tennessee, LLC | None |
| 85766-025 | Tobramycin | solution | 3 mg/mL | Sportpharm LLC | None |
| 70756-617 | Tobramycin | solution | 300 mg/4mL | Lifestar Pharma LLC | None |
| 72603-630 | Tobramycin | solution | 300 mg/4mL | NorthStar RxLLC | None |
| 0093-4085 | Tobramycin | solution | 300 mg/5mL | Teva Pharmaceuticals USA, Inc. | None |
| 47335-171 | Tobramycin | solution | 300 mg/5mL | Sun Pharmaceutical Industries, Inc. | None |
| 59651-129 | TOBRAMYCIN | solution | 300 mg/5mL | Aurobindo Pharma Limited | None |
Showing 40 of 67 listings.
Questions
Is tobramycin a controlled substance?
No. Tobramycin is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tobramycin is not on the DEA controlled substances list.
Is tobramycin a narcotic?
No. Tobramycin is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Aminoglycoside Antibacterial.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Tobramycin
- What is Tobramycin used for?FDA label uses
- Generic for NebcinFDA Orange Book
- Generic for TobrexFDA Orange Book
- Generic for TOBI PodhalerFDA Orange Book
- Generic for BethkisFDA Orange Book
- Generic for Kitabis PakFDA Orange Book
- Generic for TobiFDA Orange Book
- Aminoglycoside Antibacterials listFDA drug class
- NDC 0078-0813Tobramycin NDC record
- NDC 10122-820Tobramycin NDC record
- NDC 24492-850Tobramycin NDC record